Aerie Pharma (AERI) Tops Q4 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Aerie Pharma (AERI) Tops Q4 EPS by 8c

Aerie Pharmaceuticals Reports Year End 2015 Financial Results and Provides Business Update

March 1, 2016 4:01 PM EST

- Company on Track to File NDA in 3Q 2016 for RhopressaTM (netarsudil ophthalmic solution) 0.02% -

Conference Call and Webcast Today, March 1, at 5:00 p.m. ET

IRVINE, Calif.--(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today reported financial results for the fourth quarter and year ended December 31, 2015, along with a general business update.

Aerie Highlights

... More